Perspectives of Optimizer® Patients
Meet some our success stories – teacher, job title, etc. we invite to take a closer look
The CFDA Approves Impulse Dynamics’ Optimizer System for Treatment of Chronic Heart Failure in China
NEWSThe CFDA Approves Impulse Dynamics’ Optimizer System for Treatment of Chronic Heart Failure in ChinaOrangeburg, New York & Stuttgart, Germany. December 18, 2017 – The China Food and Drug Administration (CFDA) has approved Impulse Dynamics’ Optimizer® system...
Impulse Dynamics Announces First US Implant in the FIX-HF-5CA Continued Access Study.
NEWSImpulse Dynamics Announces First US Implant in the FIX-HF-5CA Continued Access Study.Orangeburg, New York. August 7, 2017 – Impulse Dynamics announced today the first implant in the Company’s FIX-HF-5CA Continued Access Study. The FIX-HF-5CA study is a...
Impulse Dynamics Completes $45 million Financing Round
NEWSImpulse Dynamics Completes $45 million Financing RoundStuttgart, May 11, 2017 – Impulse Dynamics, developer of the revolutionary Cardiac Contractility Modulation (CCM) technology for treatment of Chronic Heart Failure (CHF), announced today that the company has...
Impulse Dynamics Successfully Launches the Optimizer Smart Device for Heart Failure Treatment in Europe
NEWSImpulse Dynamics Successfully Launches the Optimizer Smart Device for Heart Failure Treatment in EuropeImpulse Dynamics has launched the next generation of its Optimizer device, the Optimizer Smart, in Europe after it received the CE mark. The Optimizer Smart is a...
Impulse Dynamics Recognized with Frost & Sullivan’s 2016 New Product Innovation Award
NEWSImpulse Dynamics Recognized with Frost & Sullivan’s 2016 New Product Innovation AwardSeptember 12, 2016 – Impulse Dynamics, developer of the Optimizer™ IVs implantable device for the treatment of Chronic Heart Failure (CHF), is the recipient of the prestigious...
Impulse Dynamics Completes $30 Million Financing Round
NEWSImpulse Dynamics Completes $30 Million Financing RoundMt. Laurel, New Jersey, May 13 2016 – Impulse Dynamics, developer of the Optimizer™ IVs implantable device for treatment of chronic heart failure (CHF), announced today that the company has closed a $30 million...
Continued growth within Europe – Impulse Dynamics announces the first implantations of the Optimizer IVs device in the Slovenia.
NEWSContinued growth within Europe – Impulse Dynamics announces the first implantations of the Optimizer IVs device in the Slovenia.Stuttgart, Germany, March 2016 - Impulse Dynamics announced the first two implantations of its Optimizer IVs device in Slovenia. The...
Impulse Dynamics Opens its Hong Kong Sales and Support Office
NEWSImpulse Dynamics Opens its Hong Kong Sales and Support OfficeHong Kong, China – January 11th, 2016 – Impulse Dynamics NV (Impulse), the developer of the Optimizer™ IVs implantable device, is pleased to announce the official opening of its Hong Kong sales and...
Continued Expansion for Impulse Dynamics’ Optimizer™ IVs Device – First Implant in the Emirate of Sharjah (UAE)
NEWSContinued Expansion for Impulse Dynamics’ Optimizer™ IVs Device – First Implant in the Emirate of Sharjah (UAE)Stuttgart, Germany, November 11th, 2015 – Impulse Dynamics reported today the first implantation of its Optimizer IVs device in the Emirate of Sharjah...
First Implant in the Kingdom of Saudi Arabia – Continued Global Growth for Impulse Dynamics’ Optimizer IVs Device.
NEWS First Implant in the Kingdom of Saudi Arabia – Continued Global Growth for Impulse Dynamics’ Optimizer IVs Device. Stuttgart, Germany – August 23rd, 2015 – Impulse Dynamics announced today (23 August, 2015) the first implantation of its Optimizer IVs device in...
